Key Events This Week
16 Mar: Technical momentum shifts amid mixed signals
17 Mar: Valuation upgrade enhances price attractiveness
20 Mar: Week closes at Rs.352.15 (+9.81%) outperforming Sensex
May 22
BSE+NSE Vol: 7.35 k
The next results date for Fermenta Biotech Ltd is scheduled for 26 May 2026....
Read full news article
Fermenta Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 May 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
At Rs 248.85, sellers were still queuing — but there were no buyers willing to take the other side. Fermenta Biotech Ltd locked at its lower circuit of 20% on 4 May 2026, with unfilled sell orders and a frozen price that capped losses for the day.
Read full news article
Fermenta Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Apr 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 01 May 2026, providing investors with the latest perspective on the company’s position.
Read full news article
Fermenta Biotech Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 17 April 2026, driven by a complex interplay of valuation improvements, deteriorating financial trends, weak quality metrics, and unfavourable technical signals. Despite a very attractive valuation profile, the company’s long-term fundamentals and recent quarterly performance have raised significant concerns among analysts, prompting a reassessment of its investment appeal.
Read full news article
Fermenta Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 17 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Fermenta Biotech Ltd has seen a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, despite recent market headwinds and a downgrade in its overall mojo grade to Sell. This change reflects a notable improvement in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positioning the micro-cap pharmaceutical and biotechnology firm as a compelling value proposition relative to its peers and historical benchmarks.
Read full news article
Fermenta Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article